Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Role of paclitaxel and cisplatin as the neoadjuvant treatment for locally advanced squamous cell carcinoma of the vulva.

Raspagliesi F, Zanaboni F, Martinelli F, Scasso S, Laufer J, Ditto A.

J Gynecol Oncol. 2014 Jan;25(1):22-9. doi: 10.3802/jgo.2014.25.1.22. Epub 2014 Jan 8.

2.
3.

Neoadjuvant chemotherapy with cisplatin, ifosfamide and paclitaxel for locally advanced squamous-cell cervical cancer.

Zanetta G, Lissoni A, Pellegrino A, Sessa C, Colombo N, Gueli-Alletti D, Mangioni C.

Ann Oncol. 1998 Sep;9(9):977-80.

PMID:
9818071
4.

A phase II study of multimodality treatment for locally advanced cervical cancer: neoadjuvant carboplatin and paclitaxel followed by radical hysterectomy and adjuvant cisplatin chemoradiation.

Dueñas-Gonzalez A, López-Graniel C, González-Enciso A, Cetina L, Rivera L, Mariscal I, Montalvo G, Gómez E, de la Garza J, Chanona G, Mohar A.

Ann Oncol. 2003 Aug;14(8):1278-84.

PMID:
12881393
5.

Efficacy and tolerability of paclitaxel, ifosfamide, and cisplatin as a neoadjuvant chemotherapy in locally advanced cervical carcinoma.

Scandurra G, Scibilia G, Banna GL, D'Agate G, Lipari H, Gieri S, Scollo P.

J Gynecol Oncol. 2015 Apr;26(2):118-24. doi: 10.3802/jgo.2015.26.2.118. Epub 2015 Feb 4.

6.

Neoadjuvant chemoradiotherapy followed by surgery in locally advanced squamous cell carcinoma of the vulva.

Gaudineau A, Weitbruch D, Quetin P, Heymann S, Petit T, Volkmar P, Bodin F, Velten M, Rodier JF.

Oncol Lett. 2012 Oct;4(4):719-722. Epub 2012 Jul 27.

7.

Weekly paclitaxel/carboplatin in the treatment of locally advanced, recurrent, or metastatic vulvar cancer.

Han SN, Vergote I, Amant F.

Int J Gynecol Cancer. 2012 Jun;22(5):865-8. doi: 10.1097/IGC.0b013e31824b4058.

PMID:
22552830
8.

Old and new perspectives in the management of high-risk, locally advanced or recurrent, and metastatic vulvar cancer.

Gadducci A, Cionini L, Romanini A, Fanucchi A, Genazzani AR.

Crit Rev Oncol Hematol. 2006 Dec;60(3):227-41. Epub 2006 Sep 1. Review.

PMID:
16945551
9.

Phase II trial of paclitaxel, fluorouracil, and cisplatin in patients with advanced carcinoma of the esophagus.

Ilson DH, Ajani J, Bhalla K, Forastiere A, Huang Y, Patel P, Martin L, Donegan J, Pazdur R, Reed C, Kelsen DP.

J Clin Oncol. 1998 May;16(5):1826-34.

PMID:
9586897
10.

Concurrent cisplatin and 5-fluorouracil chemotherapy and radiation therapy for advanced-stage squamous carcinoma of the vulva.

Berek JS, Heaps JM, Fu YS, Juillard GJ, Hacker NF.

Gynecol Oncol. 1991 Sep;42(3):197-201.

PMID:
1955180
11.

Tailoring the treatment of locally advanced squamous cell carcinoma of the vulva: neoadjuvant chemotherapy followed by radical surgery: results from a multicenter study.

Aragona AM, Cuneo N, Soderini AH, Alcoba E, Greco A, Reyes C, Lekmann S.

Int J Gynecol Cancer. 2012 Sep;22(7):1258-63. doi: 10.1097/IGC.0b013e318263ef55.

PMID:
22864334
12.

Docetaxel and cisplatin: an active regimen in patients with locally advanced, recurrent or metastatic squamous cell carcinoma of the head and neck. Results of a phase II study of the EORTC Early Clinical Studies Group.

Schöffski P, Catimel G, Planting AS, Droz JP, Verweij J, Schrijvers D, Gras L, Schrijvers A, Wanders J, Hanauske AR.

Ann Oncol. 1999 Jan;10(1):119-22.

PMID:
10076732
13.

Neoadjuvant treatment of locally advanced carcinoma of the uterine cervix with epirubicin, paclitaxel and cisplatin.

D'Agostino G, Distefano M, Greggi S, Salerno M, Ferrandina G, Poerio A, Mancuso S, Scambia G.

Cancer Chemother Pharmacol. 2002 Mar;49(3):256-60. Epub 2002 Jan 16.

PMID:
11935219
14.

Treatment of base of tongue cancer with paclitaxel, ifosfamide, and cisplatinum induction chemotherapy followed by chemoradiotherapy.

Hancock SB, Krempl GA, Canfield V, Bogardus C, Kojouri K, Kaneaster SK, Medina JE.

Laryngoscope. 2008 Aug;118(8):1357-61. doi: 10.1097/MLG.0b013e318175336a.

PMID:
18528311
15.

A retrospective study of patients with locally advanced cancer of the cervix treated with neoadjuvant chemotherapy followed by radical surgery.

Kumar JV, Doval DC, Rao R, Rawal S.

Int J Gynecol Cancer. 2009 Apr;19(3):417-22. doi: 10.1111/IGC.0b013e3181a1c6df.

PMID:
19407570
16.

[Phase II clinical trial of neoadjuvant therapy with carboplatin plus paclitaxel for locally advanced triple-negative breast cancer].

Ma WY, Zhang P, Zhang BL, Wang X, Xu XZ, Zheng S, Wang JY, Cai RG, Yuan P, Ma F, Fan Y, Xu BH.

Zhonghua Zhong Liu Za Zhi. 2012 Oct;34(10):770-4. doi: 10.3760/cma.j.issn.0253-3766.2012.10.011. Chinese.

PMID:
23291072
17.

Neoadjuvant chemotherapy followed by robotic radical hysterectomy in locally advanced cervical cancer: a multi-institution study.

Vizza E, Corrado G, Zanagnolo V, Tomaselli T, Cutillo G, Mancini E, Maggioni A.

Gynecol Oncol. 2014 May;133(2):180-5. doi: 10.1016/j.ygyno.2014.02.035. Epub 2014 Mar 1.

PMID:
24589412
18.

Ifosfamide, paclitaxel and cisplatin first-line chemotherapy in advanced, suboptimally debulked epithelial ovarian cancer.

Papadimitriou CA, Kouroussis C, Moulopoulos LA, Vlahos G, Rodolakis A, Kiamouris C, Diakomanolis E, Gika D, Michalas S, Dimopoulos MA.

Cancer. 2001 Oct 1;92(7):1856-63.

PMID:
11745258
19.

Long-Term Clinical Benefits of Neoadjuvant Chemotherapy in Women With Locally Advanced Cervical Cancer: Validity of Pathological Response as Surrogate Endpoint of Survival.

Buda A, Lissoni AA, Floriani I, Biagioli E, Gerardi C, Bonazzi C, Chiari S, Locatelli L, Dell'Anna T, Signorelli M, Mangioni C, Milani R.

Int J Gynecol Cancer. 2015 Oct;25(8):1468-75. doi: 10.1097/IGC.0000000000000515.

PMID:
26222484
20.

Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study.

Pagliaro LC, Williams DL, Daliani D, Williams MB, Osai W, Kincaid M, Wen S, Thall PF, Pettaway CA.

J Clin Oncol. 2010 Aug 20;28(24):3851-7. doi: 10.1200/JCO.2010.29.5477. Epub 2010 Jul 12.

Supplemental Content

Support Center